Recombinant HRP Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Mouse IgG1 (Chimeric) (ab273169)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- HRP Mouse monoclonal [H6] to SARS-CoV-2 spike glycoprotein - Chimeric
- Suitable for: ELISA
- Conjugation: HRP
Related conjugates and formulations
Overview
-
Product name
HRP Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Mouse IgG1 (Chimeric)
See all SARS-CoV-2 Spike Glycoprotein primary antibodies -
Description
HRP Mouse monoclonal [H6] to SARS-CoV-2 spike glycoprotein - Chimeric -
Host species
Mouse -
Conjugation
HRP -
Tested applications
Suitable for: ELISAmore details -
Species reactivity
Reacts with: SARS-CoV-2 -
Immunogen
Recombinant fragment corresponding to Human SARS-CoV-2 spike glycoprotein aa 16-685.
Database link: P0DTC2 -
General notes
Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Chimeric (ab272854) is a recombinant human/mouse chimeric monoclonal antibody consisting of Mouse scFv fused with human IgG1.
As the Fc region is human, an anti-Human secondary antibody should be used for detection.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. Store In the Dark. -
Storage buffer
pH: 7.40
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol (glycerin, glycerine), PBS -
Concentration information loading...
-
Purity
Affinity purified -
Clonality
Monoclonal -
Clone number
H6 -
Isotype
IgG1 -
Research areas
Associated products
-
Alternative Versions
-
Related Products
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab273169 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ELISA |
Use at an assay dependent concentration.
|
Notes |
---|
ELISA
Use at an assay dependent concentration. |
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (2)
ab273169 has been referenced in 2 publications.
- Bellier B et al. A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity. Front Immunol 13:837443 (2022). PubMed: 35281065
- Lainšcek D et al. A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response. Vaccines (Basel) 9:N/A (2021). PubMed: 33925446